This is an online synopsis of the topic which shows the executive summary and key contacts sections. To view the full document, please download it.
|Topic title||Viral Hepatitis (2014)|
|Topic owner||Health Protection Strategy Group|
|Topic author(s)||Libby Lomas|
|Topic quality reviewed||4th August 2014|
|Topic endorsed by||Health Protection Strategy Group, September 2014|
|Topic approved by||Health Protection Strategy Group, September 2014|
|Current version||17th September 2014|
|Replaces version||14th August 2014|
|Linked JSNA topics|
|Insight Document ID||107190|
Hepatitis B and hepatitis C (HBV and HCV) are blood borne viral infections that can lead to chronic infection. Without treatment these infections can lead to cirrhosis of the liver and liver cancer therefore causing significant costs to the health of the individual and the services providing treatment and care.
Given the clinical and social manifestation of HBV and HCV (complex sometimes asymptomatic diseases often associated with vulnerable groups such as injecting drug users) infected individuals can often go undiagnosed. In turn this increases the risk of liver disease and death.
Prevention, early diagnosis, treatment and aftercare provide the framework for a comprehensive and robust strategic approach.
Lack of knowledge and awareness among professionals, the public and at risk groups.
Implement programmes to increase awareness among health professionals, the general public and those at increased risk.